Finding Alzheimer’s imaging centers involves asking your doctor for referrals to hospitals and diagnostic imaging facilities in your area that offer PET, MRI, or CT scans. These tests help detect brain changes associated with Alzheimer’s disease, though no single imaging scan can diagnose the condition outright—they work alongside cognitive testing, medical history, and blood biomarkers to build a complete picture. Most major medical centers and hospital systems now have dedicated neurology or radiology departments equipped for advanced brain imaging. A patient with memory concerns in a mid-sized city might be referred to the hospital’s memory disorders clinic, which coordinates imaging appointments with the radiology department in the same building.
Smaller towns may require traveling to a regional medical center or university hospital where specialized imaging equipment and expertise are available. The specific tests available depend on your location’s resources and your doctor’s recommendations. While PET scanning (particularly amyloid or tau PET) offers the most direct look at Alzheimer’s pathology, it’s not available everywhere—many smaller hospitals offer only MRI or CT. Cost, insurance coverage, and whether you’re being evaluated for research versus clinical care also influence what testing becomes practical in your area.
Table of Contents
- What Brain Imaging Tests Can Show About Alzheimer’s Disease
- How Different Brain Imaging Methods Compare and What They Cost
- Who Should Get Alzheimer’s Imaging and at What Stage of Cognitive Change
- How to Find and Schedule Imaging at Alzheimer’s Centers Near You
- Limitations and Risks You Should Know Before Getting Imaged
- What Your Imaging Results Mean and What Comes Next
- Insurance Coverage and Cost Reality for Brain Imaging
- Frequently Asked Questions
What Brain Imaging Tests Can Show About Alzheimer’s Disease
Alzheimer’s imaging tests detect two hallmark problems in the brain: amyloid plaques and tau tangles, which form between and within nerve cells and are linked to cognitive decline. PET (positron emission tomography) scans using amyloid tracers or tau tracers can visualize these deposits directly, lighting up regions where they accumulate. MRI (magnetic resonance imaging) shows brain structure and can reveal shrinkage in the hippocampus and cortex—areas critical for memory and thinking—which occurs as neurons die. CT scans are faster but less detailed than MRI and are typically used to rule out other causes like stroke or bleeding rather than to detect Alzheimer’s changes.
The advantage of PET imaging is specificity: it can distinguish between amyloid and tau, which helps researchers and clinicians understand disease stage and progression. However, finding these deposits doesn’t automatically mean someone has dementia—some cognitively normal people show amyloid on PET scans, and not all people with amyloid will develop symptoms. This disconnect between imaging findings and clinical reality is a major reason imaging is not used alone to diagnose Alzheimer’s. MRI is more widely available and less expensive than PET, making it the first-line imaging test at many centers. It’s particularly useful for detecting brain atrophy patterns and for ruling out other causes of cognitive decline like tumor, subdural hematoma, or normal pressure hydrocephalus. If an MRI shows significant shrinkage concentrated in the medial temporal lobe, it raises suspicion for Alzheimer’s, but again, this finding must be combined with other clinical evidence.
How Different Brain Imaging Methods Compare and What They Cost
PET imaging is the most advanced and specific tool but also the most expensive and time-consuming, often costing in the hundreds to several thousands of dollars per scan depending on the tracer, facility, and insurance. A tau PET scan requires injection of a radioactive tracer and a one- to three-hour scanning session; results aren’t available the same day. PET is primarily offered at academic medical centers, specialized memory clinics, and hospitals with nuclear medicine departments. Insurance may cover it only if prior cognitive testing and MRI have been completed, or it may not cover it at all if it’s considered experimental for your specific indication. MRI is faster—typically 30 minutes to an hour—and more accessible, with machines in virtually every hospital and many outpatient imaging centers.
Cost is generally lower than PET, often a few hundred dollars with insurance. However, MRI requires lying still in a loud, confined tube, which some patients find intolerable, and it’s contraindicated for people with certain metal implants. Standard structural MRI shows brain anatomy and volume but doesn’t directly visualize amyloid or tau; advanced techniques like amyloid-weighted imaging or quantitative susceptibility mapping can hint at pathology but aren’t standard clinical practice yet. CT scans are quick—typically 15 minutes or less—and relatively affordable, often costing under a few hundred dollars with insurance. However, CT exposes you to radiation and shows less detail than MRI, so it’s not ideal for longitudinal monitoring or for detecting subtle brain changes. One limitation to keep in mind: a normal MRI or CT doesn’t rule out Alzheimer’s disease, because pathologic changes can exist without structural shrinkage, especially in early stages.
Who Should Get Alzheimer’s Imaging and at What Stage of Cognitive Change
Imaging is most useful when someone is experiencing noticeable memory loss or cognitive change that affects daily function—the point at which a diagnosis of mild cognitive impairment (MCI) or dementia is being considered. If you or a family member has been struggling to remember recent conversations, getting lost in familiar places, or having difficulty managing finances or medications, a visit to a primary care doctor or neurologist is the first step, not directly to imaging. The doctor will do cognitive testing (like the Mini-Cog or Montreal Cognitive Assessment) and take a history; only if results suggest cognitive impairment will imaging typically be ordered. Imaging is less helpful—and less commonly done—in people with subjective cognitive complaints (worrying about memory loss but performing normally on testing) or in asymptomatic people who happen to have a family history of Alzheimer’s.
Some research centers offer amyloid or tau PET to cognitively normal people as part of studies investigating who will decline over time, but this isn’t standard clinical care and raises complex questions about how to counsel someone who finds pathology but has no symptoms. A typical scenario: a 72-year-old notices she’s repeating herself and forgetting names; her daughter notices it too. The doctor does cognitive testing, finds mild impairment, and orders an mri to check for brain shrinkage, then discusses whether PET would add useful information. Timing matters because very early Alzheimer’s—the amyloid and tau phase before symptoms—is being detected and studied more now, thanks to new blood biomarkers and imaging. Some researchers advocate for screening older adults without symptoms to identify those at risk for future decline, but standard clinical practice remains to image people with cognitive symptoms.
How to Find and Schedule Imaging at Alzheimer’s Centers Near You
Start by talking to your primary care doctor or ask for a referral to a neurologist or memory disorders specialist. These clinicians have relationships with local imaging centers and know which facilities have the equipment and expertise you need. If you’re in a major metro area, search online for “memory disorders clinic” or “neuropsychology clinic” plus your city; these centers typically have in-house imaging or reliable referral networks. University hospitals and large medical centers are more likely to offer advanced imaging like PET, while smaller hospitals and independent imaging centers may offer only MRI or CT. When you contact an imaging center, ask whether they’re in your insurance network and whether your specific test requires prior authorization. Insurance companies often require proof of cognitive testing before approving imaging, or they may require MRI before amyloid PET.
Be prepared to provide your doctor’s referral and recent cognitive test results if available. Ask about wait times—some centers have several-week delays, while others can schedule within days. Also ask whether the facility has experience with patients who have cognitive impairment; some centers are set up for younger, cognitively intact patients and may not have staff trained to manage someone with memory loss who becomes anxious in the scanner. Cost varies widely and depends on whether you have insurance, the specific test, your deductible and copay, and your out-of-pocket maximum. A patient with good insurance might pay a few hundred dollars out of pocket for an MRI; without insurance, the same MRI could cost significantly more. Uninsured patients should ask the imaging center about cash-pay discounts or sliding scale fees. If you’re struggling with affordability, ask your doctor whether a clinical trial related to Alzheimer’s imaging or treatment might cover the cost—these trials often include free or subsidized imaging as part of the research protocol.
Limitations and Risks You Should Know Before Getting Imaged
No brain imaging test is perfect, and all carry trade-offs. PET imaging exposes you to radiation (roughly equivalent to a year of natural background radiation for a typical amyloid PET scan), which means it’s not ideal for frequent repeat imaging or for younger patients. MRI is very safe but can trigger panic attacks or claustrophobia in people who feel trapped in enclosed spaces; open MRI machines reduce this risk but provide lower image quality. CT exposes you to more radiation than MRI or PET and is best used sparingly. Overdiagnosis is a real risk: discovering amyloid on a PET scan in someone without symptoms can cause anxiety and may lead to unnecessary treatment with anti-amyloid drugs, which themselves carry risks and side effects.
Conversely, a normal MRI or CT doesn’t rule out Alzheimer’s disease, especially if symptoms are present; this false reassurance can delay further investigation or specialist evaluation. Some people pursue imaging hoping for a definitive diagnosis, only to find that results are inconclusive or conflicting—for example, significant brain shrinkage on MRI but no amyloid on PET, which suggests a different form of dementia like frontotemporal dementia or Lewy body disease. Accessibility and equity issues exist: advanced imaging is concentrated in urban academic centers, leaving rural and underserved communities with limited options. Patients without insurance or with poor insurance coverage may be priced out of testing, skewing diagnosis toward wealthier populations. Cognitive decline itself can make the imaging experience difficult—lying still for an hour, following instructions, or tolerating a noisy machine can be harder for someone with agitation or inability to concentrate.
What Your Imaging Results Mean and What Comes Next
When you receive imaging results, expect a radiologist’s report describing what was seen—for example, “mild cortical atrophy” or “no acute intracranial abnormality.” This report is often written in technical language and may not directly say whether Alzheimer’s is present. Your doctor will interpret the results in the context of your cognitive testing, history, blood biomarkers, and symptoms. A 78-year-old with memory loss, an MRI showing hippocampal atrophy, and a positive amyloid PET scan has strong evidence of Alzheimer’s disease; the same MRI and PET in a 65-year-old with no cognitive complaints suggests preclinical Alzheimer’s and requires discussion about surveillance, lifestyle changes, and potential future risk.
If imaging findings align with your symptoms and cognitive test results, the diagnosis becomes more solid, and your doctor can discuss treatment options—which now include anti-amyloid monoclonal antibodies that can slow cognitive decline in early symptomatic Alzheimer’s. If results are unexpected or inconclusive, additional testing like blood biomarkers (plasma phospho-tau or phospho-tau to amyloid ratios) may be recommended to clarify. Some centers perform repeat imaging every 12-24 months to track progression, though this practice isn’t standard everywhere and adds cost.
Insurance Coverage and Cost Reality for Brain Imaging
Insurance coverage for Alzheimer’s imaging varies significantly by plan, by diagnosis, and by the type of imaging. Medicare typically covers MRI and CT for evaluation of cognitive symptoms but is more restrictive with PET scans, requiring documented cognitive impairment and often requiring MRI to be done first to rule out other causes. Private insurance plans vary widely—some cover amyloid or tau PET readily with a specialist referral, while others classify it as experimental and don’t cover it at all.
Out-of-pocket costs for uninsured patients can be substantial: a single MRI scan might cost hundreds to a few thousand dollars; a PET scan can range higher depending on the tracer and facility. Some centers offer self-pay discounts if you pay upfront, and some communities have nonprofit or public health department resources for low-income patients seeking diagnostic imaging. Ask about these options directly—many centers have payment assistance programs or sliding scales that aren’t advertised. Participation in research studies is another path: clinical trials investigating new Alzheimer’s treatments or imaging techniques often provide free or subsidized imaging as part of the protocol, though enrollment requires meeting specific criteria including age, cognitive status, and geographic location.
- —
Frequently Asked Questions
Can an MRI or PET scan diagnose Alzheimer’s on its own?
No. Imaging is one tool among many. A diagnosis of Alzheimer’s requires cognitive testing, medical history, imaging findings, and increasingly, blood or cerebrospinal fluid biomarkers. Imaging alone cannot confirm Alzheimer’s, though it can support the diagnosis if results fit the clinical picture.
How long does it take to get imaging results?
MRI and CT results are typically available within 24-48 hours; a radiologist reads the scan and sends the report to your doctor. PET results take longer because the tracer must be prepared and the scan is more complex—results may take several days to a week. Your doctor will discuss findings at a follow-up visit.
What if imaging shows brain shrinkage but my cognitive tests are normal?
This happens and doesn’t necessarily mean you’re fine. Brain changes can precede symptoms. Your doctor will likely recommend repeat cognitive testing in 6-12 months and possibly repeat imaging to watch for progression, especially if blood biomarkers also suggest Alzheimer’s pathology.
Is one imaging test better than others for diagnosing Alzheimer’s?
Each test answers different questions. MRI is best for ruling out other causes and seeing brain structure; PET is best for seeing amyloid and tau pathology directly. Most centers start with MRI because it’s more available and less expensive; PET is often added if MRI is inconclusive or if you’re being considered for a clinical trial.
Are there risks to brain imaging?
PET and CT expose you to radiation; repeated imaging increases cumulative dose. MRI is very safe but can trigger anxiety in some people, and it’s not safe if you have certain metal implants. Overdiagnosis is a risk—finding amyloid in an asymptomatic person can cause worry and may lead to treatment you don’t need.
Can I get imaging at my local hospital or do I need a specialized memory center?
Most hospitals can do MRI or CT, but specialized memory clinics and academic centers are more likely to have PET imaging and staff experienced in cognitive disorders. Ask your doctor whether local imaging is appropriate or whether referral to a specialized center makes sense. —
